Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial

Aung Myat1,2, David Hildick-Smith1, Adam J de Belder1

  • 1Sussex Cardiac Centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom.

Insights

The EXCEL trial found similar outcomes for percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) for left main disease, regardless of location. However, North American patients undergoing PCI had higher rates of repeat revascularization.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Trials

Background:

  • The EXCEL trial previously demonstrated comparable five-year outcomes for PCI and CABG in treating obstructive left main coronary artery disease (LMCAD).
  • This analysis investigates geographical variations in these outcomes.

Purpose of the Study:

  • To assess if the outcomes of PCI versus CABG for LMCAD in the EXCEL trial differ based on the region of patient enrollment (European Union vs. North America).

Main Methods:

  • A prespecified subgroup analysis of the EXCEL trial was conducted, stratifying patients by their geographical enrollment center (EU vs. NA).
  • Comparison of primary and secondary composite endpoints between PCI and CABG groups within each geographical subgroup.

Main Results:

  • While the primary composite endpoint (death, MI, stroke) at 30 days and 5 years showed consistency between PCI and CABG across EU and NA centers, significant geographical differences emerged for secondary outcomes.
  • North American participants treated with PCI experienced substantially higher rates of late ischemia-driven revascularization (IDR) compared to European participants.
  • This led to a significant difference in the five-year secondary composite outcome (death, MI, stroke, or IDR) between the regions (p=0.02).

Conclusions:

  • The effectiveness of PCI relative to CABG for the primary composite outcome in LMCAD is consistent across European and North American centers.
  • Higher rates of ischemia-driven revascularization after PCI in North American centers warrant consideration in treatment decisions for patients with LMCAD.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
57
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
101
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
558
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
121
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
294
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
5.2K